 |
| |
Minomic International was established in 2007 to commercialise biomarkers for diagnosis and treatment of major diseases. Through an exclusive agreement Minomic Pty Ltd, the company will launch a diagnosis for Prostate Cancer and for Type 2 Diabetes. Headquartered in Sydney, Australia, Minomic International is currently a publicly unlisted company.
|
|
 |
| |
PROSTATE CANCER TESTING SET TO INCREASE
Prostate Cancer tests are set to increase dramatically with the aid of a new diagnostic being developed...
|
| |
| Read More : |
| |
MINOMIC INTERNATIONAL TO COMMERCIALISE PROSTATE CANCER AND DIABETES (TYPE 2) DIAGNOSTICS
Minomic International Limited has commenced its international marketing.... |
| |
| Read More : |
|
